CMS Issues Proposed Rule to Lower Out of Pocket Medicare Part D Prescription Drug Costs

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would make updates to the Medicare Advantage (MA) and Medicare Part D programs that would lower out-of-pocket prescription drug costs for beneficiaries with Medicare Part D and improve price transparency and market competition.

The proposed rule would improve beneficiaries’ experiences with MA and Part D, with a strong emphasis on individuals who are dually eligible for Medicare and Medicaid. Ultimately, CMS is taking action to hold MA and Part D plans to a higher standard in offering benefits and improve health equity in the programs.

Read more:

• Fact sheet detailing the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P)